![](/img/cover-not-exists.png)
306: Successful phase II trial using mesenchymal stem cells (MSC) in combination with steroid therapy for the primary treatment of acute graft-vs-host disease (aGVHD)
P. Kebriaei, L. Isola, E. Bahceci, H.K. Holland, S. Rowley, J. McGuirk, M. Devetten, J. Jansen, R. Herzig, M. Schuster, J. UbertiVolume:
13
Year:
2007
Language:
english
DOI:
10.1016/j.bbmt.2006.12.311
File:
PDF, 60 KB
english, 2007